Sami Bourgeois
Nurse Practitioner · Lake Charles, LANPI 1972928398
Payments from drug & device makers
Across 287 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$477
- Novo Nordisk$438
- AstraZeneca$325
- Lilly USA, LLC$220
- Merck$197
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,495100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 84 | $1,144 |
| Astellas Pharma US Inc | 27 | $477 |
| Novo Nordisk | 29 | $438 |
| AstraZeneca | 15 | $325 |
| Lilly USA, LLC | 17 | $220 |
| Merck | 11 | $197 |
| Pfizer | 9 | $182 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $156 |
| GSK | 9 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $123 |
| Amarin Pharma, Inc. | 7 | $122 |
| Boehringer Ingelheim | 8 | $111 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $95 |
| Abbott | 5 | $78 |
| Esperion Therapeutics, Inc. | 5 | $77 |
| Bayer | 4 | $75 |
| Biogen | 4 | $69 |
| Axsome Therapeutics, Inc. | 4 | $66 |
| Novartis | 4 | $64 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Convatec Inc. | 1 | $29 |
| Amgen | 2 | $24 |
| Ardelyx, Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
| Corium, LLC | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,495 in reported general payments places this provider in the 90th percentile of 969 nurse practitioner providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $81,555 |
| VraylarCariprazine Hcl | 38 | $54,535 |
| TrulicityDulaglutide | 36 | $48,617 |
| FarxigaDapagliflozin Propanediol | 19 | $28,601 |
| JardianceEmpagliflozin | 23 | $26,845 |
| MounjaroTirzepatide | 18 | $26,524 |
| LinzessLinaclotide | 22 | $20,988 |
| NexlizetBempedoic Acid/Ezetimibe | 20 | $17,738 |
| TradjentaLinagliptin | 13 | $16,099 |
| Xigduo XrDapaglifloz Propaned/Metformin | 18 | $13,489 |
| MyrbetriqMirabegron | 13 | $10,245 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $4,479 |
| Gabapentin | 86 | $1,271 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $1,269 |
| Rosuvastatin Calcium | 85 | $946 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $438 | $81,55569 claims |
| AbbVieVraylar, Linzess | $1,144 | $75,52360 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $220 | $75,14154 claims |
| Boehringer IngelheimJardiance, Tradjenta | $111 | $42,94436 claims |
| AstraZenecaFarxiga | $325 | $28,60119 claims |
| Esperion Therapeutics, Inc.Nexlizet | $77 | $17,73820 claims |
| Astellas Pharma US IncMyrbetriq | $477 | $10,24513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 969 nurse practitioner providers in Louisiana.
Other nurse practitioner in Lake Charles
- Lacey VasilakisLake Charles$17K
- Chad HodgeLake Charles$11K
- Karen DeshotelLafayette$264K
- Christopher ManuelKaplan$145K
- Tammy BennettShreveport$99K
- Jessica BordelonHammond$78K
- Teri DugganBossier City$67K
- Matt LandryLafayette$50K
- Cynthia CobbLafayette$48K
- Ellen GentileWest Monroe$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.